NCT01002118View on ClinicalTrials.gov

Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 25, 2008

Primary Completion Date

February 23, 2011

Study Completion Date

February 23, 2011

Conditions
Cardiovascular Disease
Interventions
DRUG

Omega-3 Acid Ethyl Esters

1 gram capsules Omega-3 Acid Ethyl Esters for a total of 4 grams (4 capsules) per day for 16 weeks

DRUG

Placebo

4 capsules each day for 16 weeks

Trial Locations (1)

52242

University of Iowa, Iowa City

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Iowa

OTHER